Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation

Biochemical Pharmacology

Volumn 76, Issue 4, 2008, Pages 520-530

  Wang, Shu Xiu ^a,b   Fan, Zhen Chuan ^a   Tao, Ya Xiong ^a  

^a AUBURN UNIVERSITY   (United States)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

G protein coupled receptor; Ligand binding; Melanocortin 3 receptor; Signaling; Site directed mutagenesis; Structure function relationship

Indexed keywords

ACID; ALPHA INTERMEDIN; CYCLIC AMP; MELANOCORTIN 3 RECEPTOR;

ARTICLE; CELL STRAIN HEK293; CELL SURFACE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LIGAND BINDING; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING;

ALPHA-MSH; AMINO ACIDS, ACIDIC; CELL LINE; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RECEPTOR, MELANOCORTIN, TYPE 3; SIGNAL TRANSDUCTION;

EID: 48349087119     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.05.026     Document Type: Article

References (56)

1. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268 (1993) 8246-8250
2. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., et al. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90 (1993) 8856-8860
3. Getting S.J., Christian H.C., Lam C.W., Gavins F.N., Flower R.J., Schioth H.B., et al. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170 (2003) 3323-3330
4. Getting S.J., Di Filippo C., Christian H.C., Lam C.W., Rossi F., D'Amico M., et al. MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J Leukoc Biol 76 (2004) 845-853
5. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
6. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 (2000) 97-102
7. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141 (2000) 3518-3521
8. Zhang Y., Kilroy G.E., Henagan T.M., Prpic-Uhing V., Richards W.G., Bannon A.W., et al. Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J 19 (2005) 1482-1491
9. Marks D.L., Hruby V., Brookhart G., and Cone R.D. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 27 (2006) 259-264
10. Lee M., Kim A., Conwell I.M., Hruby V., Mayorov A., Cai M., et al. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 29 (2008) 440-447
11. Hani E.H., Dupont S., Durand E., Dina C., Gallina S., Gantz I., et al. Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 86 (2001) 2895-2898
12. Lee Y.S., Poh L.K., Kek B.L., and Loke K.Y. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 56 (2007) 2622-2630
13. Lee Y.S., Poh L.K., and Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87 (2002) 1423-1426
14. Tao Y.X. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim Biophys Acta 1772 (2007) 1167-1174
15. Mencarelli M., Walker G.E., Maestrini S., Alberti L., Verti B., Brunani A., et al. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 16 (2008) 581-586
16. Tao Y.X., and Segaloff D.L. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 89 (2004) 3936-3942
17. Rached M., Buronfosse A., Begeot M., and Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta 1689 (2004) 229-234
18. Feng N., Young S.F., Aguilera G., Puricelli E., Adler-Wailes D.C., Sebring N.G., et al. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 54 (2005) 2663-2667
19. Santoro N., Perrone L., Cirillo G., Raimondo P., Amato A., Brienza C., et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr 85 (2007) 950-953
20. Rutanen J., Pihlajamaki J., Vanttinen M., Salmenniemi U., Ruotsalainen E., Kuulasmaa T., et al. Single nucleotide polymorphisms of the melanocortin-3 receptor gene are associated with substrate oxidation and first-phase insulin secretion in offspring of type 2 diabetic subjects. J Clin Endocrinol Metab 92 (2007) 1112-1117
21. Sutton G.M., Trevaskis J.L., Hulver M.W., McMillan R.P., Markward N.J., Babin M.J., et al. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147 (2006) 2183-2196
22. Versteeg D.H., Van Bergen P., Adan R.A., and De Wildt D.J. Melanocortins and cardiovascular regulation. Eur J Pharmacol 360 (1998) 1-14
23. Ni X.P., Pearce D., Butler A.A., Cone R.D., and Humphreys M.H. Genetic disruption of γ-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 111 (2003) 1251-1258
24. Humphreys M.H. γ-MSH, sodium metabolism, and salt-sensitive hypertension. Am J Physiol 286 (2004) R417-R430
25. Getting S.J., Lam C.W., Leoni G., Gavins F.N., Grieco P., and Perretti M. [D-Trp8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse). Mol Pharmacol 70 (2006) 1850-1855
26. Yang Y.K., Fong T.M., Dickinson C.J., Mao C., Li J.Y., Tota M.R., et al. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 39 (2000) 14900-14911
27. Haskell-Luevano C., Cone R.D., Monck E.K., and Wan Y.P. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40 (2001) 6164-6179
28. Lee E.J., Lee S.H., Jung J.W., Lee W., Kim B.J., Park K.W., et al. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. Eur J Biochem 268 (2001) 582-591
29. Hruby V.J., Wilkes B.C., Hadley M.E., Al-Obeidi F., Sawyer T.K., Staples D.J., et al. α-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem 30 (1987) 2126-2130
30. Tao Y.X., and Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144 (2003) 4544-4551
31. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7 (1987) 2745-2752
32. Fan Z.C., Sartin J.L., and Tao Y.X. Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J Endocrinol 196 (2008) 139-148
33. Tao Y.X., Johnson N.B., and Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279 (2004) 5904-5914
34. 8 on human MC3 receptor selectivity. J Med Chem 43 (2000) 4998-5002
35. Holder J.R., and Haskell-Luevano C. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med Res Rev 24 (2004) 325-356
36. Nickolls S.A., Cismowski M.I., Wang X., Wolff M., Conlon P.J., and Maki R.A. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity. J Pharmacol Exp Ther 304 (2003) 1217-1227
37. Zhou W., Flanagan C., Ballesteros J.A., Konvicka K., Davidson J.S., Weinstein H., et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 45 (1994) 165-170
38. Wilson M.H., Highfield H.A., and Limbird L.E. The role of a conserved inter-transmembrane domain interface in regulating alpha(2a)-adrenergic receptor conformational stability and cell-surface turnover. Mol Pharmacol 59 (2001) 929-938
39. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 (2000) 739-745
40. Bee M.S., and Hulme E.C. Functional analysis of transmembrane domain 2 of the M1 muscarinic acetylcholine receptor. J Biol Chem 282 (2007) 32471-32479
41. 2-adrenergic receptor-G-protein interactions. J Biol Chem 269 (1994) 29557-29564
42. Tao Q., and Abood M.E. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. J Pharmacol Exp Ther 285 (1998) 651-658
43. Roche J.P., Bounds S., Brown S., and Mackie K. A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol Pharmacol 56 (1999) 611-618
44. Biebermann H., Krude H., Elsner A., Chubanov V., Gudermann T., and Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52 (2003) 2984-2988
45. 2-adrenergic receptor function. Science 318 (2007) 1266-1273
46. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21 (2000) 90-113
47. 2-adrenergic receptor. Biochemistry 34 (1995) 15407-15414
48. Hunyady L., Bor M., Baukal A.J., Balla T., and Catt K.J. A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type 1 angiotensin II receptor. J Biol Chem 270 (1995) 16602-16609
49. Mitchell R., McCulloch D., Lutz E., Johnson M., MacKenzie C., Fennell M., et al. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392 (1998) 411-414
50. Prioleau C., Visiers I., Ebersole B.J., Weinstein H., and Sealfon S.C. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem 277 (2002) 36577-36584
51. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239 (2005) 1-14
52. Tao Y.X., and Segaloff D.L. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J Clin Endocrinol Metab 90 (2005) 5632-5638
53. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111 (2006) 949-973
54. Spalding T.A., Ma J.N., Ott T.R., Friberg M., Bajpai A., Bradley S.R., et al. Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation. Mol Pharmacol 70 (2006) 1974-1983
55. Lu Z.L., Gallagher R., Sellar R., Coetsee M., and Millar R.P. Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations. J Biol Chem 280 (2005) 29796-29803
56. Chen M., Aprahamian C.J., Celik A., Georgeson K.E., Garvey W.T., Harmon C.M., et al. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry 45 (2006) 1128-1137